Mateja Kernjak Slak

1. KERNJAK SLAK, Mateja. Pomen določitve serumskega pankrina pri bolnikih z vnetjem trebušne slinavke = The role of serum pankrin determination in patients with pancreatitis : diplomska naloga. Ljubljana: [Kernjak Slak, M.], 2004. 45 f. Fakulteta za farmacijo, Ljubljana, Visoškošolski študij laboratorijske biomedicine, 158/2004. [COBISS.SI-ID 1606001]

2. DROBNE, David, KURENT, Tina, RAJAR, Polona, KERNJAK SLAK, Mateja, KOŽELJ, Matic, NOVAK, Gregor, SMREKAR, Nataša, PLUT, Samo, ŠMID, Lojze, OSREDKAR, Joško, ŠTABUC, Borut, FERKOLJ, Ivan. High infliximab trough levels are associated with better control of inflammation in IBD. Gastroenterology. 2016, vol. 150, iss. 4, suppl. 1, str. s422-s423. ISSN 0016-5085. [COBISS.SI-ID 5692844]

3. KERNJAK SLAK, Mateja. Koncentracija inflikimaba kot bioznačevalec kronične vnetne črevesne bolezni = Infliximab through as a biomarker for inflammatory bowel disease : magistrska naloga : magistrski študij laboratorijske biomedicine. Ljubljana: [M. Kernjak Slak], 2016. XIV, 57 f., I-VI, ilustr., tabele. http://www.ffa.uni-lj.si/docs/default-source/knjiznica-doc/magistrske/kernjak_slak_mateja_mag_nal_2016.pdf?sfvrsn=2, Repozitorij Univerze v Ljubljani – RUL. [COBISS.SI-ID 4115313]

4. OSREDKAR, Joško, KERNJAK SLAK, Mateja, FABJAN, Teja, KUMER, Kristina, BOŽNAR ALIČ, Elizabeta, DROBNE, David, ŠTABUC, Borut. The level of infliximab as a biomarker of chronic inflammatory bowel disease treatment. V: Abstracts. 5th Slovenian Congress of Clinical Chemistry and Laboratory Medicine, Portorož, Slovenia September 30 - October 1, 2016. [Berlin]: De Gruyter, 2016. Str. ea141, p2. Clinical chemistry and laboratory medicine (Internet), Vol. 54, no. 9. ISSN 1437-4331. https://www.degruyter.com/view/j/cclm.2016.54.issue-9/cclm-2016-0624/cclm-2016-0624.xml?format=INT. [COBISS.SI-ID 4193905]